40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?

Koy Chong Ng Kee Kwong, Pratap K. Harbham, Bhuvaneish T. Selvaraj, Jenna Gregory, Suvankar Pal, Giles E. Hardingham, Siddharthan Chandran, Arpan R. Mehta* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Based on early evidence of in vitro neurotoxicity following exposure to serum derived from patients with amyotrophic lateral sclerosis (ALS), several studies have attempted to explore whether cerebrospinal fluid (CSF) obtained from people with ALS could possess similar properties. Although initial findings proved inconclusive, it is now increasingly recognized that ALS-CSF may exert toxicity both in vitro and in vivo. Nevertheless, the mechanism underlying CSF-induced neurodegeneration remains unclear. This review aims to summarize the 40-year long history of CSF toxicity studies in ALS, while discussing the various mechanisms that have been proposed, including glutamate excitotoxicity, proteotoxicity and oxidative stress. Furthermore, we consider the potential implications of a toxic CSF circulatory system in the pathophysiology of ALS, and also assess its significance in the context of current ALS research.
Original languageEnglish
Article number647895
Number of pages11
JournalFrontiers in Molecular Neuroscience
Publication statusPublished - 18 Mar 2021


  • amyotrophic lateral sclerosis
  • , cerebrospinal fluid
  • motor neuron disease
  • neurodegeneration
  • pathophysiology
  • toxicity


Dive into the research topics of '40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?'. Together they form a unique fingerprint.

Cite this